semaglutide eligibility across all current indications for us adults Most viewed this week from JAMA Internal Medicine: 50 mg of oral # daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian with overweight or # A Cardiovascular Indication for Oral

Rather than stopping tirzepatide completely, many patients benefit from continuing at a lower maintenance dose or switching to a lower-cost alternative like compounded semaglutide, which activates GLP-1 alone and may cost less while still providing meaningful appetite control

Endocrinology 155, 28582867

Lancet Phase 2 cagrilintide monotherapy trial (PMID 34480864) Enebo LB et al

What are the side effects of psyllium supplements

There was no significant effect of GW treatment on extracellular CXCL11 and a trend toward a reduction in extracellular CCL2 on day 2 ( p = 0.053), while there was no effect on day 5 (Supplementary Fig

& Walterova, D